» Articles » PMID: 30807353

Study on Variation Trend of Repetitive Nerve Stimulation Waveform in Amyotrophic Lateral Sclerosis

Overview
Specialty General Medicine
Date 2019 Feb 27
PMID 30807353
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease involving both upper and lower motor neurons with no effective cure. Electrophysiological studies have found decremental responses during low-frequency repetitive nerve stimulation (RNS) except for diffused neurogenic activities. However, the difference between ALS and generalized myasthenia gravis (GMG) in terms of waveform features is unclear. In the current study, we explored the variation trend of the amplitudes curve between ALS and GMG with low-frequency, positive RNS, and the possible mechanism is discussed preliminarily.

Methods: A total of 85 ALS patients and 41 GMG patients were recruited. All patients were from Peking Union Medical College Hospital (PUMCH) between July 1, 2012 and February 28, 2015. RNS study included ulnar nerve, accessory nerve and facial nerve at 3 Hz and 5 Hz stimulation. The percentage reduction in the amplitude of the fourth or fifth wave from the first wave was calculated and compared with the normal values of our hospital. A 15% decrease in amplitude is defined as a decrease in amplitude.

Results: The decremental response at low-frequency RNS showed the abnormal rate of RNS decline was 54.1% (46/85) in the ALS group, and the results of different nerves were 54.1% (46/85) of the accessory nerve, 8.2% (7/85) of the ulnar nerve and 0% (0/85) of the facial nerve stimulation, respectively. In the GMG group, the abnormal rate of RNS decline was 100% (41/41) at low-frequency RNS of accessory nerves. However, there was a significant difference between the 2 groups in the amplitude after the sixth wave.

Conclusions: Both groups of patients are able to show a decreasing amplitude of low-frequency stimulation RNS, but the recovery trend after the sixth wave has significant variation. It implies the different pathogenesis of NMJ dysfunction of these 2 diseases.

Citing Articles

Decremental response in patients with amyotrophic lateral sclerosis during repetitive nerve stimulation and its relationships with impaired homeostasis.

Zhang J, Li Y, Shi Q Front Aging Neurosci. 2025; 16():1502025.

PMID: 39839311 PMC: 11747797. DOI: 10.3389/fnagi.2024.1502025.


Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal models.

Gronnebaek T, Haahr-Lillevang H, Skov M, Kelly K, Kerr N, Viteri J Ann Clin Transl Neurol. 2024; 12(2):320-331.

PMID: 39670429 PMC: 11822784. DOI: 10.1002/acn3.52252.


Detecting muscle-specific kinase myasthenia gravis in atypical presentations.

Cheng C, Su J Acta Neurol Belg. 2024; 124(5):1733-1735.

PMID: 38555304 DOI: 10.1007/s13760-024-02530-z.


Study on the Diagnostic Value of Neuroelectrophysiological Examination in Patients with Amyotrophic Lateral Sclerosis.

Ding G, Fan Y Comput Math Methods Med. 2022; 2022:3907751.

PMID: 36276994 PMC: 9581655. DOI: 10.1155/2022/3907751.


Progressive muscle weakness and amyotrophy during pregnancy as the first manifestation of systemic lupus erythematosus: A case report and review of literature.

Wang L, Wang D, Ruan Y, Chen X, Chen W, Li Z Sci Prog. 2021; 104(4):368504211050276.

PMID: 34939871 PMC: 10450697. DOI: 10.1177/00368504211050276.


References
1.
Schoser B, Wehling S, Blottner D . Cell death and apoptosis-related proteins in muscle biopsies of sporadic amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve. 2001; 24(8):1083-9. DOI: 10.1002/mus.1114. View

2.
Brooks B, Miller R, Swash M, Munsat T . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9. DOI: 10.1080/146608200300079536. View

3.
Hensley K, Floyd R, Gordon B, Mou S, Pye Q, Stewart C . Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem. 2002; 82(2):365-74. DOI: 10.1046/j.1471-4159.2002.00968.x. View

4.
del Aguila M, Longstreth Jr W, McGuire V, Koepsell T, van Belle G . Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003; 60(5):813-9. DOI: 10.1212/01.wnl.0000049472.47709.3b. View

5.
MULDER D, LAMBERT E, EATON L . Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology. 1959; 9:627-31. DOI: 10.1212/wnl.9.10.627. View